Dow Up1.30% Nasdaq Up0.37%

Catalyst Pharmaceutical Partners Inc. (CPRX)

-NasdaqCM
2.74 0.03(1.11%) Oct 30, 4:00PM EDT
CompetitorsGet Competitors for:
Direct Competitor Comparison 
CPRXPVT1PVT2SNYIndustry
Market Cap:184.04MN/AN/A119.93B1.02B
Employees:7N/AN/A112,128571.00
Qtrly Rev Growth (yoy):N/AN/AN/A0.040.13
Revenue (ttm): N/AN/AN/A42.65B720.66M
Gross Margin (ttm):N/AN/AN/A0.670.54
EBITDA (ttm):-12.43MN/AN/A12.93B28.89M
Operating Margin (ttm): N/AN/AN/A0.200.11
Net Income (ttm):-14.28MN/AN/A5.24BN/A
EPS (ttm):-0.26N/AN/A1.960.26
P/E (ttm):N/AN/AN/A23.3026.76
PEG (5 yr expected):N/AN/AN/A2.910.99
P/S (ttm):N/AN/AN/A2.793.72
 
Pvt1 = Lundbeck Inc. (privately held)
Pvt2 = Novartis Corporation (privately held)
SNY = Sanofi
Industry = Drugs - Generic

Biotechnology Companies Ranked By Sales 
CompanySymbolPriceChangeMarket CapP/E
Amgen Inc.AMGN161.580.02122.96B25.44
Genentech, Inc.Private - View Profile
Biogen Idec Inc.BIIB321.000.0275.81B30.40
Genzyme CorporationPrivate - View Profile
Merck Serono S.A.Private - View Profile
Gilead Sciences Inc.GILD114.220.03172.92B20.35
MedImmune, L.L.C.Private - View Profile
Life Technologies CorporationPrivate - View Profile
Teva Pharmaceutical Industries LimitedTEVA56.470.0448.21B18.60
Sandoz International GmbHPrivate - View Profile
 
View Drugs - Generic Industry Center

Generic Drugmakers Ranked by Sales 
CompanySymbolPriceChangeMarket CapP/E
Actavis plcACT243.210.0264.27B638.35
Ranbaxy Laboratories LimitedPrivate - View Profile
Mylan, Inc.MYL52.370.0319.59B35.65
Pfizer Inc.PFE29.840.01189.21B18.48
Johnson & JohnsonJNJ107.040.01301.88B17.72
GlaxoSmithKline plcGSK45.140.00108.52B16.32
SanofiSNY45.700.01119.93B23.30
Novartis AGNVS91.950.01222.70B21.13
Roche Holding AGRHHBY37.180.01252.63B22.66
AstraZeneca PLCAZN72.600.0191.69B45.29
 
View Drugs - Generic Industry Center

Drugmakers Ranked By Sales 
CompanySymbolPriceChangeMarket CapP/E
Abbott LaboratoriesABT43.490.0265.40B34.30
Bristol-Myers Squibb CompanyBMY58.980.0997.83B36.41
 
View Drugs - Generic Industry Center

 
News on Direct Competitors 

Currency in USD.